StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX)

Investment analysts at StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 2.5 % EGRX opened at $3.43 on Wednesday. The company’s 50-day moving […]

Related Keywords

United States ,Los Angeles ,California , ,Eagle Pharmaceuticals Inc ,Los Angeles Capital Management ,News Ratings For Eagle Pharmaceuticals Daily ,Eagle Pharmaceuticals ,Eagle Pharmaceuticals Company Profile ,Institutional Trading Of Eagle Pharmaceuticals ,Eagle Pharmaceuticals Stock ,Get Free Report ,Investment Partners ,Angeles Capital Management ,Capital Partners ,Financial Markets ,Eagle Pharmaceuticals Daily ,